Integra LifeSciences IART EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Integra LifeSciences’s reported figures.
Based on trailing twelve months.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's EBITDA margin?
- Integra LifeSciences (IART) reported EBITDA margin of -19.5% in Q1 2026.
- How has Integra LifeSciences's EBITDA margin changed year-over-year?
- Integra LifeSciences's EBITDA margin decreased by 285.2% year-over-year, from 10.5% to -19.5%.
- What is the long-term trend for Integra LifeSciences's EBITDA margin?
- Over 5 years (2020 to 2025), Integra LifeSciences's EBITDA margin has grown at a 0.9% compound annual growth rate (CAGR), from 20.4% to -21.4%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.